Ret Proto-Oncogene anticorps (AA 361-458)
Aperçu rapide pour Ret Proto-Oncogene anticorps (AA 361-458) (ABIN1930190)
Antigène
Voir toutes Ret Proto-Oncogene (RET) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Épitope
- AA 361-458
-
Specificité
- Human RET
-
Purification
- Purified from ascites by Protein A
-
Immunogène
-
RET (AAH03072, aa361-458 partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.
Type of Immunogen: GST fusion protein -
Isotype
- IgG2a kappa
-
-
-
-
Indications d'application
-
Approved: ELISA, IHC, IHC-P (10 μg/mL), WB
Usage: Sandwich ELISA: Recombinant protein. Western Blot: Recombinant protein. -
Commentaires
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- PBS, pH 7.4.
-
Conseil sur la manipulation
- Aliquot to avoid repeated freezing and thawing.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C or lower. Aliquot to avoid freeze-thaw cycles.
-
-
- Ret Proto-Oncogene (RET)
-
Autre désignation
- RET
-
Sujet
-
Name/Gene ID: RET
Subfamily: Cadherin
Family: Protein Kinase
Synonyms: RET, Cadherin family member 12, CDHF12, C-ret, Hirschsprung disease 1, HSCR1, Hydroxyaryl-protein kinase, Oncogene ret, Proto-oncogene c-Ret, RET-ELE1, RET51, Ret proto-oncogene, RET transforming sequence, RET43, Men2-ret, MEN2B, MTC1, Receptor tyrosine kinase, CDHR16, MEN2A, PTC, RET9 -
ID gène
- 5979
-
Pathways
- Signalisation RTK, Dopaminergic Neurogenesis, Regulation of Cell Size, Tube Formation
Antigène
-